233 related articles for article (PubMed ID: 19482475)
1. NOEY2 mutations in primary breast cancers and breast hyperplasia.
Yang J; Hu A; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T
Breast; 2009 Jun; 18(3):197-203. PubMed ID: 19482475
[TBL] [Abstract][Full Text] [Related]
2. [NOEY2 gene mRNA expression in breast cancer tissue and its relation to clinicopathological parameters].
Shi Z; Zhou X; Xu L; Zhang T; Hou Y; Zhu W; Zhang T
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):475-8. PubMed ID: 12485503
[TBL] [Abstract][Full Text] [Related]
3. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
4. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
Majumdar S; Diamandis EP
Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
6. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.
Li Y; Wei Q; Cao F; Cao X
Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370
[TBL] [Abstract][Full Text] [Related]
7. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutation spectrum in breast cancers and breast hyperplasia.
Yang J; Ren Y; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T; Dai F
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1303-11. PubMed ID: 20300775
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
10. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the DBC2 gene in sporadic and familial breast cancer.
Ohadi M; Totonchi M; Maguire P; Lindblom A; Habibi R; Alavi BA; Keyhani E; Najmabadi H
Acta Oncol; 2007; 46(6):770-2. PubMed ID: 17653899
[TBL] [Abstract][Full Text] [Related]
12. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
13. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
Meng J; Shi YR; Niu RF; Fu L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
Fan P; Wu Z; Cha X; Wang X; Wang S
Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
Yu Q; Niu Y; Yu Y; Ding X; Shi Y
Breast Cancer Res Treat; 2009 Apr; 114(3):433-40. PubMed ID: 18425676
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
19. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
Canbay E; Degerli N; Gulluoglu BM; Kaya H; Sen M; Bardakci F
Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
[TBL] [Abstract][Full Text] [Related]
20. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
